Sanpower
Valeant to sell cancer business to Sanpower for $820m
January 10, 2017Manufacturing and Production, Sales and Marketing Dendreon, Sanpower, Valeant
Valeant Pharmaceuticals has announced it is to sell its cancer business Dendreon to Chinese firm Sanpower in a deal worth …
Latest content
Highlighting the value of lab research for healthcare innovation
November 2, 2026
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
